Fen Ye

Director, Rwe Solid Tumor @Novartis

Integral partner of business strategy development in collaboration with R&D, V&A, commercial and medical affairs • Responsible for portfolio level RWE strategies development and execution of and tactical plan for lung cancer • Leadership in building collaborative network (internal and external) for evidence generation and dissemination • Create fit-for-purpose RWE solutions for drug development, regulatory submission, payer negotiation, launch preparation, and global/local RWE strategy synchronization • Advocate for innovative RWE and establish use cases for decision making, including: prospective RWE, hybrid design, tokenization, external control, machine learning, deep molecular RWE, and digital RWE platform